Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0110731004
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Cancelled Post Market | 00557773 | WYETH LTD. | ATIVAN INJ 4MG/ML | Human | No | TARGETED SUBSTANCES (CDSA IV) | 1 | LORAZEPAM | 4 MG / ML |
| Cancelled Post Market | 02041405 | WYETH CANADA | ATIVAN INJECTION LIQ 4MG/ML | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | LORAZEPAM | 4 MG / ML |
| Marketed | 02243278 | SANDOZ CANADA INCORPORATED | LORAZEPAM INJECTION USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | LORAZEPAM | 4 MG / ML |
| Cancelled Post Market | 02388669 | PFIZER CANADA ULC | LORAZEPAM INJECTION USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | LORAZEPAM | 4 MG / ML |
| Marketed | 02550962 | FRESENIUS KABI CANADA LTD | LORAZEPAM INJECTION, USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | LORAZEPAM | 4 MG / ML |
Application information
Related information
Contact us
Version 4.1.0